Buy & Sell iShares 20 Plus Year Treasury Bond ETF (TLT) – iShares 20 Plus Year Treasury Bond ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Sector
- -8.59%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 68 daysTypical Hold Time
Over the past 52 weeks, iShares 20 Plus Year Treasury Bond ETF has traded between a low of $83.02 and a high of $92.06, highlighting its annual price range. Over the past three months, iShares 20 Plus Year Treasury Bond ETF has recorded a drawdown of -8.59%, reflecting recent price volatility. On average, investors hold iShares 20 Plus Year Treasury Bond ETF for approximately 68 days, indicating typical investor behavior on the platform.
About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Most Recent News
Bempedoic acid shows promise in lowering LDL-C in children and statin-intolerant adults, per Esperion data.
Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...

Rhythm Pharmaceuticals to present at major healthcare conferences in June 2026
Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and acce...

Virax Biolabs reports positive early data for ViraxImmune™, a test for Long COVID and related syndromes.
Virax Biolabs announced encouraging early pilot data for ViraxImmune™, a blood test in development to detect Long COVID, ME/CFS, and related post-acute infection syndromes. The test showed 88% specificity and 92% positive predictive value in distingu...
